Mega Medika Mandiri is primarily engaged in pharmaceuticals activity. Its headquarters is located in Dki Jakarta. The company was founded in 1999. Mega Medika Mandiri was established by a group of visionary entrepreneurs with a mission to improve healthcare accessibility and quality in Indonesia. The company focuses on the production and distribution of a wide range of pharmaceutical products, including prescription medications, over-the-counter drugs, and health supplements. As a key player in the Indonesian pharmaceutical industry, Mega Medika Mandiri operates several branches across major cities in Indonesia, ensuring a robust local presence. The company is committed to expanding its reach and currently exports its products to several Southeast Asian countries, contributing to the region's healthcare sector. The company's product portfolio includes well-known brands that cater to various therapeutic areas such as cardiovascular health, diabetes management, and respiratory care. Mega Medika Mandiri is dedicated to research and development, continuously innovating to meet the evolving needs of healthcare professionals and patients. In addition to its core pharmaceutical business, the company has established strategic partnerships with international pharmaceutical firms to enhance its product offerings and technological capabilities. Mega Medika Mandiri is a member of several industry associations, actively participating in initiatives to promote healthcare advancements in Indonesia. The company envisions becoming a leading pharmaceutical provider in Asia, driven by its commitment to quality, innovation, and customer satisfaction. Mega Medika Mandiri's mission is to deliver affordable and effective healthcare solutions, improving the well-being of communities it serves.
Headquarters
Gedung MTH Square Lantai 3, Jalan MT Haryono Kav 10
East Jakarta; Jakarta;
Postal Code: 13320
Contact Details: Purchase the PT Mega Medika Mandiri report to view the information.
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service